Jonathan Colasanti retweetledi

Incredibly proud of the Ponce LA ART program team for spearheading use of the HIV treatment innovation equitably and with such care and compassion @JColasantiMD #endingtheepidemic
Clinical Infectious Diseases@CIDJournal
Long-acting cabotegravir/rilpivirine, lenacapavir, and ibalizumab use among persons with HIV-1 viremia at a Ryan White-funded clinic in the urban U.S. South ✅ Just Accepted ✍️ @lfcollins_md bit.ly/3IVZNxb
English





















